2.9517
3.46%
-0.2283
アフターアワーズ:
2.83
-0.1217
-4.12%
前日終値:
$3.18
開ける:
$3.11
24時間の取引高:
41,874
Relative Volume:
1.21
時価総額:
$26.77M
収益:
-
当期純損益:
$-8.24M
株価収益率:
-1.8921
EPS:
-1.56
ネットキャッシュフロー:
$-16.44M
1週間 パフォーマンス:
-12.29%
1か月 パフォーマンス:
-17.03%
6か月 パフォーマンス:
-24.90%
1年 パフォーマンス:
+18.08%
Marker Therapeutics Inc Stock (MRKR) Company Profile
名前
Marker Therapeutics Inc
セクター
電話
(713) 400-6400
住所
2450 HOLCOMBE BLVD, HOUSTON, TX
MRKR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
MRKR | 2.9517 | 26.77M | 0 | -8.24M | -16.44M | -1.56 |
VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-03-25 | 開始されました | Piper Sandler | Overweight |
2021-03-19 | 開始されました | Cantor Fitzgerald | Overweight |
2020-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
2019-05-30 | 開始されました | ROTH Capital | Buy |
2019-03-01 | 開始されました | Janney | Buy |
2018-12-03 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Marker Therapeutics Inc (MRKR) 最新ニュース
Hematopoietic Stem Cell Transplantation Market to Exhibit - openPR
Silence Therapeutics' Zerlasiran Shows 90% Reduction in Key Heart Disease Marker | SLN Stock News - StockTitan
Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Precision Optics Receives Initial Production Order for Single-Use Ophthalmic Program - The Manila Times
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
Marker Therapeutics Secures $4M NIH Grants, Reports Promising MT-601 Trial Progress | MRKR Stock News - StockTitan
Marker Therapeutics Inc (MRKR) Quarterly 10-Q Report - Quartzy
Alterity's Advanced Brain Imaging Breakthrough Reveals New MSA Disease Progression Marker | ATHE Stock News - StockTitan
Dr Truong on the Background of the ImmunoCobiVem Trial in BRAF V600+ Melanoma - OncLive
MAGEA4 Opens the Door for Engineered Cellular Therapies in Solid Tumors - OncLive
US Penny Stocks To Consider In October 2024 - Simply Wall St
Allogeneic Hematopoietic Stem Cell Transplant Market to - GlobeNewswire
Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight - India Shorts
Kids Marker Market to hit USD 257.4 million by 2032, says Global Market Insights Inc. - Yahoo Finance
PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - PR Newswire UK
Omega Therapeutics stock hits 52-week low at $1.2 - Investing.com
AML cell therapy trials to watch in 2024 targeting GvHD - Yahoo Finance
Markforged (NYSE:MKFG) Sees Unusually-High Trading Volume - Defense World
Top 3 Health Care Stocks That May Explode This Month - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines
On Tuesday’s show: Medical 'Blind Spots' - WJCT NEWS
ProShare Advisors LLC Has $47.68 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna - PR Newswire
ProShare Advisors LLC Sells 43,073 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
AI Is Poised to Influence Several Areas of Cancer Care With Some Fine-Tuning - OncLive
Meiji Yasuda Asset Management Co Ltd. Has $580,000 Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Washington Journal: Dr. Marty Makary Discusses His Book "Blind Spots" & Health Care in the U.S. - C-SPAN
Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch
Hematopoietic Stem Cell Transplantation Global Market Report 2024 Size and Forecast - WhaTech
Edgestream Partners L.P. Invests $1.67 Million in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Moderna Inc [NASDAQ: MRNA] Sees Decrease in Stock Value - Knox Daily
Hematopoietic stem cell transplantation (HSCT) Market to See - openPR
Down 13% in 1 Day, Is Moderna Stock in Trouble? - The Motley Fool
Quest Partners LLC Trims Stock Position in Marsh & McLennan Companies, Inc. (NYSE:MMC) - MarketBeat
Moderna Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Parallel Advisors LLC Reduces Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
Dr. Marty Makary Talks "Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health" - The Clay Travis & Buck Sexton Show
Acadian Asset Management LLC Purchases New Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Dai ichi Life Insurance Company Ltd Boosts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World
AMG 193 Shows Preliminary Clinical Activity in MTAP-Deleted Solid Tumors - OncLive
Wedbush Securities Inc. Invests $393,000 in First Trust NASDAQ BuyWrite Income ETF (NASDAQ:FTQI) - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Recommendation of “Buy” from Analysts - Defense World
United Parks & Resorts Inc. (NYSE:PRKS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
VYNE Therapeutics Announces Positive Phase 1a SAD Data for VYN202, a Novel BD2-Selective BET Inhibitor - StockTitan
Palisade Bio Reports Data Demonstrating PDE4B Expression in - GlobeNewswire
Short Interest in Solventum Co. (NYSE:SOLV) Drops By 17.8% - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Short Interest Down 17.3% in August - Defense World
MYR Group Inc. (NASDAQ:MYRG) Short Interest Update - Defense World
Phillips 66 (NYSE:PSX) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Bank of New York Mellon Corp Acquires 36,810 Shares of SEI Investments (NASDAQ:SEIC) - Defense World
Anthem Blue Cross and Blue Shield unveils a new historic marker in Columbus - Yahoo Finance
Marker Therapeutics Inc (MRKR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):